Active, Not Recruiting
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
NCT04802174
- Conditions
- Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States